TEVIMBRA is a uniquely designed humanized immunoglobulin G4 (IgG4) anti-programmed cell death protein 1 (PD-1) monoclonal antibody with high affinity and binding specificity against PD-1. It is ...

The ADRIATIC study included 730 patients with stages I-III LS-SCLC who had not progressed after concurrent chemoradiotherapy. Participants were randomized to receive durvalumab, placebo ...